Potassium Citrate Tablet, Extended Release
Product Images NDC 16571-864

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 16571-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium-citrate-01 (Potassium Citrate 01)

This text is a label for Potassium Citrate Extended-Release Tablets, USP with each tablet containing 540 mg of Potassium Citrate USP. The recommended dosage information is available on the attached labeling. The tablets should be stored at temperatures between 20° to 25°C (68° to 77°F), with allowable excursions to 15° to 30°C (59° to 86°F). The container should be tightly sealed and kept out of reach of children. The product is manufactured by Rising Pharma Holdings, Inc. in India. The neutral code and revision date are also provided on the label.*

FDA Label Image

Potassium-citrate-02 (Potassium Citrate 02)

This text provides information about a medication containing Potassium Citrate with a specified dosage. It includes instructions for pharmacists regarding packaging and storage requirements. The medication is manufactured for Rising Pharma Holdings, Inc. with each tablet containing 1080 mg of Potassium Citrate. The text also includes details about its usage and storage conditions.*

FDA Label Image

Potassium-citrate-structure (Potassium Citrate Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.